REGN

$0.00

(

+0.00%

)
Quote details

stock

Regeneron Pharmaceuticals Inc

NASDAQ | REGN

572.59

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 15, 2025)

$59.35B

Market Cap

14.11

P/E Ratio

39.7

EPS

$1,160.86

52 Week High

$475.77

52 Week Low

HEALTHCARE

Sector

REGN Chart

Recent Chart
Price Action

REGN Technicals

Tags:

REGN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $12B
Total Revenue $14B
Cost Of Revenue $2.5B
Costof Goods And Services Sold $2.5B
Operating Income $4.2B
Selling General And Administrative $3B
Research And Development $4.6B
Operating Expenses $7.6B
Investment Income Net -
Net Interest Income $656M
Interest Income $711M
Interest Expense $55M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $483M
Income Before Tax $4.8B
Income Tax Expense $367M
Interest And Debt Expense -
Net Income From Continuing Operations $4.4B
Comprehensive Income Net Of Tax -
Ebit $4.8B
Ebitda $5.3B
Net Income $4.4B

Revenue & Profitability

Earnings Performance

REGN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $38B
Total Current Assets $19B
Cash And Cash Equivalents At Carrying Value $2.5B
Cash And Short Term Investments $2.5B
Inventory $3.1B
Current Net Receivables $6.2B
Total Non Current Assets $19B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.1B
Intangible Assets Excluding Goodwill $1.1B
Goodwill -
Investments -
Long Term Investments $8.9B
Short Term Investments $6.5B
Other Current Assets $349M
Other Non Current Assets -
Total Liabilities $8.4B
Total Current Liabilities $3.9B
Current Accounts Payable $790M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $4.5B
Capital Lease Obligations $720M
Long Term Debt $2B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.7B
Other Current Liabilities $2.3B
Other Non Current Liabilities $1.6B
Total Shareholder Equity $29B
Treasury Stock -
Retained Earnings $32B
Common Stock $100K
Common Stock Shares Outstanding $115M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $4.4B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $483M
Capital Expenditures $756M
Change In Receivables -
Change In Inventory -$620M
Profit Loss -
Cashflow From Investment -$2.5B
Cashflow From Financing -$2.2B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$3.6B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $4.4B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $12B
Total Revenue $14B
Cost Of Revenue $2.5B
Costof Goods And Services Sold $2.5B
Operating Income $4.2B
Selling General And Administrative $3B
Research And Development $4.6B
Operating Expenses $7.6B
Investment Income Net -
Net Interest Income $656M
Interest Income $711M
Interest Expense $55M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $483M
Income Before Tax $4.8B
Income Tax Expense $367M
Interest And Debt Expense -
Net Income From Continuing Operations $4.4B
Comprehensive Income Net Of Tax -
Ebit $4.8B
Ebitda $5.3B
Net Income $4.4B

Dividends

Field Value
Ex Dividend Date 2025-08-18
Declaration Date 2025-08-01
Record Date 2025-08-18
Payment Date 2025-09-03
Amount 0.88

REGN News

REGN Profile

Regeneron Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

ATCH
+153.84%
$0.99
GPUS
+22.35%
$0.45
CGBS
-39.47%
$0.03
BIAF
+29.77%
$0.35
TSLA
+3.56%
$410.04
BINI
+9.26%
$0.07
ATYR
-83.16%
$1.01
BITF
+9.19%
$2.43
OPI
+59.62%
$0.88
NVDA
-0.03%
$177.75
SNAP
+1.70%
$7.46
CHEK
+184.22%
$2.12
GRAB
+2.33%
$6.14
WBD
+3.12%
$19.46
AAL
-2.94%
$12.53
NAKA
-53.23%
$1.30
DNN
+8.86%
$2.58
MTVA
+115.54%
$1.50
INTC
+2.86%
$24.77
ORIS
+35.33%
$0.18
BTG
-2.22%
$4.38
MARA
-0.42%
$16.23
SOUN
+0.49%
$14.19
ADAP
+18.92%
$0.06
RR
+18.41%
$3.89
TPIC
-45.91%
$0.12
NXTT
-4.76%
$0.14
NIO
+4.34%
$6.49
AXDX
-61.36%
$0.03
SOFI
+4.21%
$27.67
AIRE
-11.03%
$1.29
JOBY
+0.85%
$14.12
GOOGL
+4.48%
$251.61
MULN
-17.14%
$0.06
RAYA
+11.21%
$0.04
BBD
+1.59%
$3.18
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
BMNR
-3.59%
$53.11
PFE
+0.41%
$23.97
PLUG
+3.28%
$1.57
BURU
-9.82%
$0.15
PLTR
-0.12%
$171.21
QBTS
+3.32%
$18.35
RGTI
+0.62%
$19.21
AAPL
+1.12%
$236.70
CIFR
0.00%
$10.85
QS
+4.12%
$10.36
ABEV
+1.30%
$2.33
MSN
+13.89%
$0.48
PR
-3.35%
$13.24
RIOT
+4.97%
$16.68
RMBL
+60.50%
$3.21
F
-0.11%
$11.66
RIG
+0.30%
$3.31
ACHR
+4.22%
$9.11
ADD
-25.47%
$0.05
ORCL
+3.40%
$302.14
FAAS
-39.19%
$0.12
IREN
+9.36%
$37.14
CRWV
+7.60%
$120.47
ONDS
-2.74%
$6.38
AMD
+1.63%
$161.16
HOOD
-0.17%
$114.83
TLRY
+5.35%
$1.18
WULF
-2.50%
$10.49
SRM
+53.27%
$10.30
IONQ
+6.29%
$59.11
RZLV
+14.20%
$7.72
AMZN
+1.43%
$231.43
FRGT
+5.67%
$1.49
KEY
-1.15%
$18.84
KDP
-1.76%
$26.75
GLUE
+44.07%
$6.93
T
+0.16%
$29.62
RIVN
+1.04%
$13.60
ONFO
+14.60%
$1.29
BTE
-0.15%
$2.36
NWTN
+3.42%
$1.51
AIIO
+3.42%
$1.51
ITUB
+2.43%
$7.14
GOOG
+4.30%
$251.76
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAC
+0.01%
$50.59
HL
+4.95%
$11.76
IHT
+66.00%
$3.32
WLGS
-5.57%
$0.04
APLD
+4.93%
$19.60
PCG
-0.71%
$15.34
LDI
+5.85%
$4.51
HIMS
-2.75%
$53.97
HBAN
-0.78%
$17.63
GPRO
+17.65%
$2.43
IBRX
+5.38%
$2.74
ETWO
0.00%
$3.30
NOK
+0.88%
$4.55
CAN
-0.77%
$0.81
SLNH
+29.76%
$0.93
CCL
-0.85%
$31.24
ATCH
+153.84%
$0.99
GPUS
+22.35%
$0.45
CGBS
-39.47%
$0.03
BIAF
+29.77%
$0.35
TSLA
+3.56%
$410.04
BINI
+9.26%
$0.07
ATYR
-83.16%
$1.01
BITF
+9.19%
$2.43
OPI
+59.62%
$0.88
NVDA
-0.03%
$177.75
SNAP
+1.70%
$7.46
CHEK
+184.22%
$2.12
GRAB
+2.33%
$6.14
WBD
+3.12%
$19.46
AAL
-2.94%
$12.53
NAKA
-53.23%
$1.30
DNN
+8.86%
$2.58
MTVA
+115.54%
$1.50
INTC
+2.86%
$24.77
ORIS
+35.33%
$0.18
BTG
-2.22%
$4.38
MARA
-0.42%
$16.23
SOUN
+0.49%
$14.19
ADAP
+18.92%
$0.06
RR
+18.41%
$3.89
TPIC
-45.91%
$0.12
NXTT
-4.76%
$0.14
NIO
+4.34%
$6.49
AXDX
-61.36%
$0.03
SOFI
+4.21%
$27.67
AIRE
-11.03%
$1.29
JOBY
+0.85%
$14.12
GOOGL
+4.48%
$251.61
MULN
-17.14%
$0.06
RAYA
+11.21%
$0.04
BBD
+1.59%
$3.18
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
BMNR
-3.59%
$53.11
PFE
+0.41%
$23.97
PLUG
+3.28%
$1.57
BURU
-9.82%
$0.15
PLTR
-0.12%
$171.21
QBTS
+3.32%
$18.35
RGTI
+0.62%
$19.21
AAPL
+1.12%
$236.70
CIFR
0.00%
$10.85
QS
+4.12%
$10.36
ABEV
+1.30%
$2.33
MSN
+13.89%
$0.48
PR
-3.35%
$13.24
RIOT
+4.97%
$16.68
RMBL
+60.50%
$3.21
F
-0.11%
$11.66
RIG
+0.30%
$3.31
ACHR
+4.22%
$9.11
ADD
-25.47%
$0.05
ORCL
+3.40%
$302.14
FAAS
-39.19%
$0.12
IREN
+9.36%
$37.14
CRWV
+7.60%
$120.47
ONDS
-2.74%
$6.38
AMD
+1.63%
$161.16
HOOD
-0.17%
$114.83
TLRY
+5.35%
$1.18
WULF
-2.50%
$10.49
SRM
+53.27%
$10.30
IONQ
+6.29%
$59.11
RZLV
+14.20%
$7.72
AMZN
+1.43%
$231.43
FRGT
+5.67%
$1.49
KEY
-1.15%
$18.84
KDP
-1.76%
$26.75
GLUE
+44.07%
$6.93
T
+0.16%
$29.62
RIVN
+1.04%
$13.60
ONFO
+14.60%
$1.29
BTE
-0.15%
$2.36
NWTN
+3.42%
$1.51
AIIO
+3.42%
$1.51
ITUB
+2.43%
$7.14
GOOG
+4.30%
$251.76
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAC
+0.01%
$50.59
HL
+4.95%
$11.76
IHT
+66.00%
$3.32
WLGS
-5.57%
$0.04
APLD
+4.93%
$19.60
PCG
-0.71%
$15.34
LDI
+5.85%
$4.51
HIMS
-2.75%
$53.97
HBAN
-0.78%
$17.63
GPRO
+17.65%
$2.43
IBRX
+5.38%
$2.74
ETWO
0.00%
$3.30
NOK
+0.88%
$4.55
CAN
-0.77%
$0.81
SLNH
+29.76%
$0.93
CCL
-0.85%
$31.24

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.